The pharmaceutical industry enters 2026 in a state of structural stress. What was considered the “gold standard” of procurement efficiency for two decades—the minimum unit price—has become a systemic risk to margins, production continuity, and regulatory resilience.
In the wake of the pandemic, geopolitical fragmentation, and increased regulatory pressure, procurement is no longer a function of cost savings. It has become a mechanism for managing business survival.
In 2026, the key question for CPOs and CFOs will be different:
“It’s not how much we saved on price, but how much margin did we lose because of those savings?”
In 2024–2025, the global pharmaceutical market demonstrated a clear break in logic:
Situation (2024):
One of the top 10 global manufacturers (Novartis/Pfizer were publicly featured in industry reviews) optimized API sourcing by shifting some of the volumes to suppliers with the lowest price.
Result:
Financial effect:
Margin loss in two key products exceeded $180 million over 12 months.
Conclusion:
Price is no longer a proxy metric for efficiency.
In 2026, API sourcing is evaluated along three axes:
Cheap price without a backup scenario = latent risk of production shutdown.
Total Cost of Ownership is no longer limited to:
In 2026, TCO includes:
Regulatory requirements have become a direct cost driver.
Every supplier deviation = cost multiplier throughout the chain.
From 2025, Scope 3 will no longer be a “reporting formality”:
all of this directly affects access to funding and partnerships.
Leading companies use a Resilience Matrix, where each supplier is evaluated on:
By the end of 2026:
Before signing a contract, ask:
In 2026, it’s not those who buy cheaper who survive.
And those who think deeper.
Land restoration as an investment project: how to define a baseline, assess environmental and financial impact, take risks into account, and build a verifiable system of indicators without overpromises.
A balanced review of the potential of sapropel for soil restoration: what research shows, what tests are needed, and why there is no universal standard.
Restoration of degraded soils: why one method is not enough A degraded area often looks “obvious”: topsoil washout, compaction, uneven slopes, or water stagnation. However,…
